Close Menu

San Diego's Scripps Translational Science Institute will conduct the first study to assess whether people taking genetic tests will change their behavior, says this article in SciAm. Scripps will offer its 10,000 employees, family members, and friends of the nonprofit Scripps Health system Navigenics' genetic test, and changes in behavior will be assessed over a 20-year period. The study will be led by Eric Topol, director at Scripps.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.